Literature DB >> 32027590

Outcomes of patients with Fournier's Gangrene: 12-year experience from a tertiary care referral center.

Gaurav Garg1, Vishwajeet Singh1, Rahul Janak Sinha1, Ashish Sharma1, Siddharth Pandey1, Ajay Aggarwal1.   

Abstract

OBJECTIVE: To highlight changing trends of the clinical spectrum, and compare the management options and predictors of Fournier's gangrene (FG) outcomes in a tertiary care referral center.
MATERIAL AND METHODS: This study included patients with FG between August 2005 and July 2017. Patients were classified as "responders" and "nonresponders." We compared the baseline characteristics, clinical spectrum, biochemical data, management modalities, outcomes, and FG severity index (FGSI) and age-adjusted Charlson Comorbidity Index (ACCI) between responders and nonresponders.
RESULTS: We studied 72 patients and further divided them to responders (60 patients) and non-responders (12 patients). All were males; the mean age was 56.27+19.27 years (range, 47-85 years). The most common complaints were perineal discomfort (n=62; 86.1%) and fever (n=48; 66.7%). FG originated from the penoscrotal region in 64 patients (88.8%) and perineal region in 8 patients. Diabetes mellitus was the most common comorbidity (36%). The mean duration of the presentation was 10.19 days (range, 7-30 days). Sixteen patients underwent split skin grafting. The mortality rate was 8.3%. Nonresponders had distinct findings relative to responders: advanced age (71.5±7.17 vs. 53.23±19.85 years; p=0.00); high blood sugar (245.83±116.26 vs. 139.06±35.64 mg/dL; p<0.01); leukocytosis (27166.67±10295.75 vs. 10558.4±3130.64 cumm; p<0.01); elevated serum creatinine (3.78±1.43 vs. 1.38±1.00; p<0.01); hyponatremia (127.33±11.84 vs. 137.33±3.42 meq/l; p<0.01), elevated international normalized ratios (1.66±0.28 vs. 1.32±0.07; p<0.01); and high FGSI (9.83±1.11 vs. 6.46±1.68;p<0.01) and ACCI scores (6.33±0.49 vs. 5±0.82; p<0.01). On univariate and multivariate regression analysis, raised blood sugar and deranged international normalized ratios at presentation were significantly associated with decreased response to treatment (p<0.05).
CONCLUSION: An advanced age, diabetes mellitus, renal impairment, leukocytosis, altered sensorium, shock at presentation, deranged international normalized ratios, and high FGSI and ACCI scores can be used as predictors for poor response. FG risk scores adequately characterize the severity and prognosis of FG, but clinician's judgement is vital. The management comprises of a multidisciplinary approach, including parenteral antibiotics, urgent surgical debridement, and comorbidities optimization.

Entities:  

Year:  2019        PMID: 32027590      PMCID: PMC6922036          DOI: 10.5152/tud.2019.39586

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  22 in total

1.  Fournier's gangrene caused by Candida species as the primary organism.

Authors:  K Johnin; M Nakatoh; T Kadowaki; M Kushima; S Koizumi; Y Okada
Journal:  Urology       Date:  2000-07-01       Impact factor: 2.649

Review 2.  Fournier's gangrene: changing face of the disease.

Authors:  R J Yaghan; T M Al-Jaberi; I Bani-Hani
Journal:  Dis Colon Rectum       Date:  2000-09       Impact factor: 4.585

Review 3.  Fournier's gangrene.

Authors:  Emilio Morpurgo; Susan Galandiuk
Journal:  Surg Clin North Am       Date:  2002-12       Impact factor: 2.741

4.  Prognostic factors in Fournier gangrene.

Authors:  Jaime Ruiz-Tovar; Luis Córdoba; Jose Manuel Devesa
Journal:  Asian J Surg       Date:  2012-05-23       Impact factor: 2.767

5.  [Hyperbaric oxygen therapy adjunctive to surgical debridement in management of Fournier's gangrene: usefulness of a severity index score in predicting disease gravity and patient survival].

Authors:  A Janane; F Hajji; T O Ismail; J Chafiqui; M Ghadouane; A Ameur; M Abbar; A Albouzidi
Journal:  Actas Urol Esp       Date:  2011-04-14       Impact factor: 0.994

6.  Fournier's gangrene: a historical vignette.

Authors:  B Nathan
Journal:  Can J Surg       Date:  1998-02       Impact factor: 2.089

Review 7.  Fournier's gangrene.

Authors:  G L Smith; C B Bunker; M D Dinneen
Journal:  Br J Urol       Date:  1998-03

8.  Validation and simplification of Fournier's gangrene severity index.

Authors:  Tsung-Yen Lin; Chien-Hui Ou; Tzong-Shin Tzai; Yat-Ching Tong; Chien-Chen Chang; Hong-Lin Cheng; Wen-Horng Yang; Yung-Ming Lin
Journal:  Int J Urol       Date:  2014-03-17       Impact factor: 3.369

9.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

10.  Prognostic factors in Fournier gangrene.

Authors:  Hee Jong Jeong; Seung Chol Park; Ill Young Seo; Joung Sik Rim
Journal:  Int J Urol       Date:  2005-12       Impact factor: 3.369

View more
  1 in total

Review 1.  Practical Review of the Current Management of Fournier's Gangrene.

Authors:  Maria T Huayllani; Amandip S Cheema; Matthew J McGuire; Jeffrey E Janis
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-03-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.